• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PC1
Click for more information
9.09% 1.0¢

PLUS CONNECT LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
PC1 Activistic Forms Board of Advisors in USA31/07/15
PC1 Appointment of Director Mr Evan Cross31/07/15
PC1 Activistic prepares for Veterans Call App launch in USA29/07/15
PC1 Clarification of Disclosure22/06/15
PC1 Supplimentary Announcement regarding Chairmans appointment18/06/15
PC1 Activistic Board and Senior Management Changes18/06/15
PC1 Appendix 3B03/06/15
PC1 Link to Conference Call Recording26/05/15
PC1 Investment Presentation - May 2015 - Content20/05/15
PC1 Investment Report - Contact Details - May 201520/05/15
PC1 Investor Presentation - May 201520/05/15
PC1 Extention of MoU with YuuZooPRICE SENSITIVE19/05/15
PC1 Initial substantial holder statement18/05/15
PC1 Activistic Signs Agreement with Mobile Giving FoundationPRICE SENSITIVE15/05/15
PC1 Royal Flying Doctor Service to be Activistic's Official AustPRICE SENSITIVE15/05/15
PC1 Activistic Lists on ASX15/05/15
PC1 Securities Trading Policy13/05/15
PC1 Escrowed Securities Statement13/05/15
PC1 Top 20 shareholders13/05/15
PC1 Distribution Schedule13/05/15
PC1 Confirmation Statements and Capital Structure13/05/15
PC1 Appendix 1A and Information Form and Checklist13/05/15
PC1 Pre-Reinstatement Disclosure13/05/15
PC1 ASX Reinstatement Notice13/05/15
PC1 Reinstatement to Official Quotation (15 May 2015)PRICE SENSITIVE13/05/15
PC1 Appendix 3Y by 304/05/15
PC1 Appendix 3B01/05/15
PC1 Appendix 4C - quarterly30/04/15
PC1 Closure of Prospectus and Notification of change of name24/04/15
PC1 Supplementary Prospectus14/04/15
PC1 Waiver granted to ASX LR14.713/04/15
PC1 Amended prospectus timetable08/04/15
PC1 Ceasing to be a substantial holder02/04/15
PC1 Appendix 3B27/03/15
PC1 Prospectus25/03/15
PC1 Cancellation of Options25/03/15
PC1 Completion of consolidation20/03/15
PC1 Results of GM12/03/15
PC1 Cancellation of options11/03/15
PC1 Suspension from Official QuotationPRICE SENSITIVE11/03/15
PC1 NoM Change of Timetable11/03/15
PC1 Appendix 3B23/02/15
PC1 Response to ASX Query - Appendix 5BPRICE SENSITIVE20/02/15
PC1 Half Yearly Report and AccountsPRICE SENSITIVE20/02/15
PC1 Appendix 3B20/02/15
PC1 Appendix 3B - Completion of Consolidation17/02/15
PC1 Notice of General Meeting/Proxy Form13/02/15
PC1 Results of Meeting09/02/15
PC1 Activistic signs MoU with YuuZoo (Sgn)PRICE SENSITIVE02/02/15
PC1 Appendix 4C - quarterlyPRICE SENSITIVE30/01/15
PC1 Shareholders UpdatePRICE SENSITIVE16/01/15
PC1 Notice of General Meeting/Proxy Form07/01/15
PC1 Commercial funding update16/12/14
PC1 Change in substantial holding10/12/14
PC1 Results of Annual General Meeting26/11/14
PC1 Loan facility extensionPRICE SENSITIVE07/11/14
PC1 Appendix 4C - quarterlyPRICE SENSITIVE30/10/14
PC1 Resignation of Director22/10/14
PC1 Annual Report to shareholders21/10/14
PC1 Notification of AGM and proxy17/10/14
PC1 New Director appointed and Appendix 3X17/10/14
PC1 Appendix 3B14/10/14
PC1 Acuvax signs Agreement with ActivisticPRICE SENSITIVE07/10/14
PC1 Full Year Statutory accounts 30 June 201426/09/14
PC1 Director Appointment/Resignation29/08/14
PC1 Preliminary Final Report YE 30 June 2014PRICE SENSITIVE27/08/14
PC1 Appendix 3B and completion of raising26/08/14
PC1 Reinstatement to Official Quotation (26/08/2014)PRICE SENSITIVE25/08/14
PC1 Completion of Capital raising and prospectusPRICE SENSITIVE25/08/14
PC1 Appendix 3B and statement11/08/14
PC1 Appendix 3B statement07/08/14
PC1 Appendix 3B and Cleasing notice06/08/14
PC1 Appendix 4C - quarterly30/07/14
PC1 Results of Meeting30/07/14
PC1 Amended Appendix 3B03/07/14
PC1 Notice of General Meeting/Proxy Form01/07/14
PC1 Appendix 3B and statement27/06/14
PC1 Company Presentation24/06/14
PC1 Binding Heads of Agreement with Activistic Pty Ltd23/06/14
PC1 Placement20/06/14
PC1 Market update30/05/14
PC1 Appointment of Director and App 3X23/05/14
PC1 Appendix 4C - quarterly30/04/14
PC1 Final Director's Interest Notice14/03/14
PC1 Director resignation14/03/14
PC1 31 Dec 2013 Half Yearly Report and App4D28/02/14
PC1 Appendix 4C - quarterly29/01/14
PC1 Results of Annual General Meeting27/11/13
PC1 Appendix 4C - quarterly29/10/13
PC1 Notice of Annual General Meeting/Proxy Form24/10/13
PC1 Board Changes10/10/13
PC1 30 June 2013 Annual Report to shareholders26/09/13
PC1 Appendix 4E29/08/13
PC1 Appendix 4C - quarterly31/07/13
PC1 Close of prospectus04/07/13
PC1 Waiver from Listing Rule 14.711/06/13
PC1 Biolife presents at Asia Biotech Invest Conference07/06/13
PC1 Grant of Patent28/05/13
PC1 Extension of Offer09/05/13
PC1 Appendix 4C - quarterly30/04/13
PC1 Activistic Forms Board of Advisors in USA
31/07/15
PC1 Appointment of Director Mr Evan Cross
31/07/15
PC1 Activistic prepares for Veterans Call App launch in USA
29/07/15
PC1 Clarification of Disclosure
22/06/15
PC1 Supplimentary Announcement regarding Chairmans appointment
18/06/15
PC1 Activistic Board and Senior Management Changes
18/06/15
PC1 Appendix 3B
03/06/15
PC1 Link to Conference Call Recording
26/05/15
PC1 Investment Presentation - May 2015 - Content
20/05/15
PC1 Investment Report - Contact Details - May 2015
20/05/15
PC1 Investor Presentation - May 2015
20/05/15
PC1 Extention of MoU with YuuZoo
19/05/15PRICE SENSITIVE
PC1 Initial substantial holder statement
18/05/15
PC1 Activistic Signs Agreement with Mobile Giving Foundation
15/05/15PRICE SENSITIVE
PC1 Royal Flying Doctor Service to be Activistic's Official Aust
15/05/15PRICE SENSITIVE
PC1 Activistic Lists on ASX
15/05/15
PC1 Securities Trading Policy
13/05/15
PC1 Escrowed Securities Statement
13/05/15
PC1 Top 20 shareholders
13/05/15
PC1 Distribution Schedule
13/05/15
PC1 Confirmation Statements and Capital Structure
13/05/15
PC1 Appendix 1A and Information Form and Checklist
13/05/15
PC1 Pre-Reinstatement Disclosure
13/05/15
PC1 ASX Reinstatement Notice
13/05/15
PC1 Reinstatement to Official Quotation (15 May 2015)
13/05/15PRICE SENSITIVE
PC1 Appendix 3Y by 3
04/05/15
PC1 Appendix 3B
01/05/15
PC1 Appendix 4C - quarterly
30/04/15
PC1 Closure of Prospectus and Notification of change of name
24/04/15
PC1 Supplementary Prospectus
14/04/15
PC1 Waiver granted to ASX LR14.7
13/04/15
PC1 Amended prospectus timetable
08/04/15
PC1 Ceasing to be a substantial holder
02/04/15
PC1 Appendix 3B
27/03/15
PC1 Prospectus
25/03/15
PC1 Cancellation of Options
25/03/15
PC1 Completion of consolidation
20/03/15
PC1 Results of GM
12/03/15
PC1 Cancellation of options
11/03/15
PC1 Suspension from Official Quotation
11/03/15PRICE SENSITIVE
PC1 NoM Change of Timetable
11/03/15
PC1 Appendix 3B
23/02/15
PC1 Response to ASX Query - Appendix 5B
20/02/15PRICE SENSITIVE
PC1 Half Yearly Report and Accounts
20/02/15PRICE SENSITIVE
PC1 Appendix 3B
20/02/15
PC1 Appendix 3B - Completion of Consolidation
17/02/15
PC1 Notice of General Meeting/Proxy Form
13/02/15
PC1 Results of Meeting
09/02/15
PC1 Activistic signs MoU with YuuZoo (Sgn)
02/02/15PRICE SENSITIVE
PC1 Appendix 4C - quarterly
30/01/15PRICE SENSITIVE
PC1 Shareholders Update
16/01/15PRICE SENSITIVE
PC1 Notice of General Meeting/Proxy Form
07/01/15
PC1 Commercial funding update
16/12/14
PC1 Change in substantial holding
10/12/14
PC1 Results of Annual General Meeting
26/11/14
PC1 Loan facility extension
07/11/14PRICE SENSITIVE
PC1 Appendix 4C - quarterly
30/10/14PRICE SENSITIVE
PC1 Resignation of Director
22/10/14
PC1 Annual Report to shareholders
21/10/14
PC1 Notification of AGM and proxy
17/10/14
PC1 New Director appointed and Appendix 3X
17/10/14
PC1 Appendix 3B
14/10/14
PC1 Acuvax signs Agreement with Activistic
07/10/14PRICE SENSITIVE
PC1 Full Year Statutory accounts 30 June 2014
26/09/14
PC1 Director Appointment/Resignation
29/08/14
PC1 Preliminary Final Report YE 30 June 2014
27/08/14PRICE SENSITIVE
PC1 Appendix 3B and completion of raising
26/08/14
PC1 Reinstatement to Official Quotation (26/08/2014)
25/08/14PRICE SENSITIVE
PC1 Completion of Capital raising and prospectus
25/08/14PRICE SENSITIVE
PC1 Appendix 3B and statement
11/08/14
PC1 Appendix 3B statement
07/08/14
PC1 Appendix 3B and Cleasing notice
06/08/14
PC1 Appendix 4C - quarterly
30/07/14
PC1 Results of Meeting
30/07/14
PC1 Amended Appendix 3B
03/07/14
PC1 Notice of General Meeting/Proxy Form
01/07/14
PC1 Appendix 3B and statement
27/06/14
PC1 Company Presentation
24/06/14
PC1 Binding Heads of Agreement with Activistic Pty Ltd
23/06/14
PC1 Placement
20/06/14
PC1 Market update
30/05/14
PC1 Appointment of Director and App 3X
23/05/14
PC1 Appendix 4C - quarterly
30/04/14
PC1 Final Director's Interest Notice
14/03/14
PC1 Director resignation
14/03/14
PC1 31 Dec 2013 Half Yearly Report and App4D
28/02/14
PC1 Appendix 4C - quarterly
29/01/14
PC1 Results of Annual General Meeting
27/11/13
PC1 Appendix 4C - quarterly
29/10/13
PC1 Notice of Annual General Meeting/Proxy Form
24/10/13
PC1 Board Changes
10/10/13
PC1 30 June 2013 Annual Report to shareholders
26/09/13
PC1 Appendix 4E
29/08/13
PC1 Appendix 4C - quarterly
31/07/13
PC1 Close of prospectus
04/07/13
PC1 Waiver from Listing Rule 14.7
11/06/13
PC1 Biolife presents at Asia Biotech Invest Conference
07/06/13
PC1 Grant of Patent
28/05/13
PC1 Extension of Offer
09/05/13
PC1 Appendix 4C - quarterly
30/04/13
refresh Created with Sketch. REFRESH
 

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Leo Lithium locks in US$116.3M with sale of Goulamina stake to Ganfeng Leo Lithium has revealed it's set for a cash injection with the sale of its interest in the Goulamina Lithium Project (GLP) to Ganfeng.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.